Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-09-12 to 2025-09-15
Current total value of award: $893.52
Description: 4569629863!XIFAXAN 200 MG TABLET 30S